Skip to main content
Clinical Trials/NCT07470242
NCT07470242
Completed
Not Applicable

Effectiveness and Safety of Povidone-Iodine Irrigation for Postoperative Management of Chronic Rhinosinusitis

Pusan National University Hospital1 site in 1 country48 target enrollmentStarted: October 13, 2021Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
48
Locations
1
Primary Endpoint
Lund-Kennedy Endoscopic Score

Overview

Brief Summary

This prospective randomized controlled trial evaluates the effectiveness and safety of different nasal irrigation solutions for postoperative care after endoscopic sinus surgery in patients with chronic rhinosinusitis. Patients undergoing endoscopic sinus surgery will be randomly assigned to receive nasal irrigation with normal saline, mucomyst, or diluted povidone-iodine solution for three months after surgery. Clinical outcomes, symptom scores, endoscopic findings, and potential ototoxic effects will be evaluated to compare the effectiveness and safety of these irrigation methods.

Detailed Description

Chronic rhinosinusitis is a common inflammatory disease characterized by symptoms such as nasal obstruction, nasal discharge, facial pressure, and decreased sense of smell. Endoscopic sinus surgery (ESS) is often performed in patients whose symptoms do not improve with medical treatment. Postoperative nasal irrigation is widely used to promote mucosal healing and remove secretions in the nasal cavity and paranasal sinuses.

Povidone-iodine has broad-spectrum antimicrobial activity and is commonly used as a disinfectant. It has been suggested that diluted povidone-iodine solution may improve postoperative wound healing and provide additional antimicrobial effects when used as a nasal irrigation solution. However, concerns exist regarding the potential ototoxicity of povidone-iodine if it enters the middle ear during irrigation.

This prospective randomized controlled trial aims to evaluate the effectiveness and safety of nasal irrigation using normal saline, mucomyst, or diluted povidone-iodine solution after endoscopic sinus surgery in patients with chronic rhinosinusitis. Patients will receive nasal irrigation for three months after surgery. Clinical outcomes, symptom scores, endoscopic findings, and hearing-related tests including pure tone audiometry, tympanometry, and distortion product otoacoustic emissions will be evaluated to assess treatment effectiveness and potential ototoxicity.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients diagnosed with chronic rhinosinusitis
  • Patients who underwent endoscopic sinus surgery (ESS)
  • Patients who performed postoperative nasal irrigation for 3 months
  • Patients who completed the follow-up evaluation and agreed to participate in the study

Exclusion Criteria

  • History of chronic otitis media
  • Presence of otitis media with effusion at the time of evaluation
  • History of previous middle ear surgery
  • Known allergy to povidone-iodine
  • Incomplete follow-up data
  • Refusal to participate in the study

Arms & Interventions

Normal Saline Irrigation

Active Comparator

Patients perform nasal irrigation using normal saline solution for 3 months after endoscopic sinus surgery.

Intervention: Normal Saline Nasal Irrigation (Other)

Mucomyst Irrigation

Active Comparator

Patients perform nasal irrigation using a mucomyst solution for 3 months after endoscopic sinus surgery.

Intervention: Acetylcysteine (Mucomyst) Nasal Irrigation (Drug)

Povidone-Iodine Irrigation

Experimental

Postoperative nasal irrigation using diluted 0.5% povidone-iodine solution after endoscopic sinus surgery.

Intervention: Povidone-Iodine Nasal Irrigation (Drug)

Outcomes

Primary Outcomes

Lund-Kennedy Endoscopic Score

Time Frame: 3 months after endoscopic sinus surgery

Postoperative sinonasal status evaluated by nasal endoscopy using the Lund-Kennedy endoscopic scoring system.

Hearing function assessed by pure tone audiometry (PTA)

Time Frame: 3 months after endoscopic sinus surgery

Assessment of hearing threshold to evaluate potential ototoxicity of nasal irrigation solutions.

Secondary Outcomes

  • Sino-Nasal Outcome Test (SNOT-20) score(3 months after endoscopic sinus surgery)
  • Distortion Product Otoacoustic Emission (DPOAE)(3 months after endoscopic sinus surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sung-Won Choi

Associate Professor, Department of Otorhinolaryngology-Head and Neck Surgery

Pusan National University Hospital

Study Sites (1)

Loading locations...

Similar Trials